About Omnicare’s Court Supervised Process
Continuing Delivery of Safe and Reliable Pharmacy Services to All Customers
Court-Supervised
Sale Process
Following a comprehensive sale process, the Court approved GenieRx Holdings LLC, a joint partnership between private investment firm Milrose Capital LLC and health-care investment and management firm Integro Asset Management LLC, which does business as Integro Healthcare Services, as the buyer for the Omnicare business in full. The transaction is expected to close later this year, subject to regulatory approvals and customary closing conditions.
Throughout the process Omnicare is continuing to:
Omnicare is
Operating as Normal
From everyday care to specialized services – Omnicare is operating as normal, so our customers can focus on what matters most: meeting the healthcare needs of their long‑term care residents.
Omnicare continues to focus on helping skilled nursing and assisted living providers navigate the increasing clinical, regulatory, and operational complexity of long‑term care through thoughtful pricing approaches, clinically meaningful programs, service models designed for the realities of long term care, and ongoing engagement with our customers.
Supporting Our
Customers and Prospects
Omnicare has a proud history of providing industry‑leading pharmacy and clinical care solutions to long‑term care providers and residents. As we move through this process, our top priority continues to be providing safe and reliable pharmacy and clinical services.
Care Settings
We Support
As we emerge from restructuring, we are focused on strengthening the areas customers have told us matter most: clinical outcomes, transparency, cost optimization, and resident experience. Our 2026–2027 strategy includes enhancements to pricing, clinical capabilities, service models, and customer engagement — all designed to help you navigate the increasing acuity, regulatory, and financial demands of long-term care.
- Cost-transparent models designed to support financial predictability
- Enhanced clinical programs aligned to CMS Value-Based Purchasing (VBP) measures
- Actionable analytics that support star rating improvement, survey readiness, and demonstrated clinical value
- Clinical programs focused on reducing avoidable hospitalizations transitions of care and supporting aging-in-place
- Streamlined delivery, communication, and billing experiences designed to reduce operational friction
- Reducing administrative burden for ALFs by streamlining pharmacy coordination: supporting resident choice while minimizing the operational complexity placed on facility staff
Sales Process FAQs
- The Court approved GenieRx as the buyer for Omnicare’s business in full.
- GenieRx is a joint partnership between private investment firm Milrose Capital LLC and health-care investment and management firm Integro Asset Management LLC, which does business as Integro Healthcare Services.
- With GenieRx we will have the opportunity to strengthen how we serve, by staying disciplined in our operations, aligning closely with best practices and working in partnership with providers and communities that count on us.
Chapter 11 is a legal tool that allows companies to reorganize their finances and address liabilities while they continue operating. It does not mean that a business is shutting down.
- We were engaged in a civil lawsuit in the U.S. District Court for the Southern District of New York.
- To resolve issues related to the litigation and address other financial challenges facing the broader long-term care pharmacy industry, Omnicare initiated a voluntary court-supervised Chapter 11 process.
- This is a proactive step that enables us to move forward and help ensure the continued delivery of safe and reliable pharmacy and clinical services to our customers and residents.
- This approval marks an important step forward and provides a clear path to complete the transaction later this year, subject to regulatory approval and customary closing conditions.
- Omnicare is continuing to operate as normal.
- We remain focused on working closely with our customers and delivering safe, reliable pharmacy services.
- The Court’s approval marks an important step in our court-supervised process and clears path to close the transaction later this year.
- This announcement does not change our priorities.
- Omnicare is continuing to operate as normal as we remain focused on working closely with our customers and delivering safe, reliable pharmacy services.
- Additional stakeholder resources and information regarding the court-supervised process is available at www.OmnicareRestructuring.com.
- Court filings and other information related to the proceedings, including instructions on how to file a proof of claim, are available on a separate website administered by the Company’s claims agent, Stretto, at https://cases.stretto.com/Omnicare, by calling Stretto representatives toll-free at (833) 570-5323 or (949) 276-9547 for calls originating outside of the U.S. or Canada, or by sending an email to TeamOmnicare@stretto.com.
- Supporting our customers and residents remains our top priority.
- Throughout the court-supervised process, we remain fully committed to providing you – and all of your residents – with safe and reliable pharmacy and clinical services.
- From everyday care to specialized services – we are operating as normal, so you can focus on what matters most: meeting the pharmacy needs of your long-term care residents.
- You should expect no changes to how we serve you as we move through this process.
- From everyday care to specialized services, we remain fully committed to working closely with your healthcare facility to provide you with high quality care and meet your pharmacy needs.
- As always, delivering safe and reliable pharmacy services to the patients we serve remains our top priority.
- As we move through this process, we will continue to support your members and fill their prescriptions.
- You should expect no changes to how we work together.
- We remain fully committed to delivering safe and reliable pharmacy and clinical services to our customers and residents.
- Thank you for your continued support.
- As part of federal law under the U.S. Bankruptcy Code, we have to pay vendors and suppliers in full under normal terms for goods and services provided after the filing date.
- We have access to sufficient cash to conduct normal operations during this process, including paying our vendors.
- We rely on your cooperation – and the cooperation of all of our vendors – as you play a critical role in enabling us to provide safe and reliable pharmacy and clinical services for our customers and residents as we move through this process.
Learn More
Additional information regarding Omnicare’s court‑supervised process is available at: